文献速递复苏、休克与脓毒症中毒与环境急症

院外心脏骤停前非处方药物使用与临床结局的关联

The association of non-prescription drug use preceding out-of-hospital cardiac arrest and clinical outcomes.
PubMed 文献 · Resuscitation · 2024-07-10
一句话结论调整混杂后,非处方药物相关院外心脏骤停与良好神经功能结局及出院生存无关联,仅与自主循环恢复(ROSC)存在关联(OR 1.13)。

该研究基于不列颠哥伦比亚省心脏骤停登记库(2019年1月至2023年6月),纳入18,426例经急救医疗服务治疗的院外心脏骤停(OHCA),其中2,171例(12%)有院外心脏骤停前非处方药物使用证据,定义为院外心脏骤停前24小时内目击者陈述使用或现场发现吸毒器具。非处方药物相关院外心脏骤停(DA-OHCA)者较其他OHCA更年轻、多为无目击、多发生于夜间、初始心律多为不可除颤心律。未调整分析中,DA-OHCA组良好神经功能结局(CPC 1-2)比例更高(10% vs 8.4%,差值1.8%,95%CI 0.49-3.2),但调整模型未发现与良好神经功能结局(OR 1.08,95%CI 0.87-1.33)或出院生存(OR 1.13,95%CI 0.93-1.38)的关联,仅与ROSC存在关联(OR 1.13,95%CI 1.004-1.27)。临床意义在于,不应仅凭非处方药物使用史即对OHCA预后做出悲观判断。

要点

  • DA-OHCA占全部OHCA的12%(2,171/18,426),较其他OHCA更年轻、多为无目击、多发生于夜间、初始心律多为不可除颤心律。
  • 未调整分析:DA-OHCA组良好神经功能结局(CPC 1-2)比例为10%(221例),其他OHCA为8.4%(1,365例),差值1.8%(95%CI 0.49-3.2)。
  • 调整后DA-OHCA与良好神经功能结局无关联(OR 1.08,95%CI 0.87-1.33),与出院生存无关联(OR 1.13,95%CI 0.93-1.38)。
  • 调整后DA-OHCA与ROSC存在关联(OR 1.13,95%CI 1.004-1.27)。

适用人群与场景

  • 纳入2019年1月至2023年6月不列颠哥伦比亚省心脏骤停登记库中经急救医疗服务治疗的院外心脏骤停(OHCA)病例,共18,426例。
  • DA-OHCA定义为院外心脏骤停前有非处方药物使用证据,包括目击者陈述24小时内使用或现场发现吸毒器具;共2,171例(12%)。

研究设计与关键结果

  • 研究类型为基于不列颠哥伦比亚省心脏骤停登记库的登记研究,纳入2019年1月至2023年6月18,426例经急救医疗服务治疗的OHCA,其中DA-OHCA 2,171例(12%)。
  • DA-OHCA组较其他OHCA更年轻、多为无目击、多发生于夜间、初始心律多为不可除颤心律。
  • 未调整分析:DA-OHCA组良好神经功能结局(CPC 1-2)比例为10%(221例),其他OHCA为8.4%(1,365例),差值1.8%(95%CI 0.49-3.2)。
  • 调整模型:DA-OHCA与良好神经功能结局无关联(OR 1.08,95%CI 0.87-1.33),与出院生存无关联(OR 1.13,95%CI 0.93-1.38)。
  • 调整模型:DA-OHCA与ROSC存在关联(OR 1.13,95%CI 1.004-1.27)。

证据类型、等级与局限

  • 证据类型:基于登记库的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者指出,临床医生可能依据非处方药物使用史对OHCA做出预后判断;本研究表明调整混杂后DA-OHCA与良好神经功能结局及出院生存无关联,仅与ROSC存在关联,提示不应仅凭非处方药物使用史即做出悲观预后判断。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clinicians may make prognostication decisions for out-of-hospital cardiac arrest (OHCA) using historical details pertaining to non-prescription drug use. However, differences in outcomes between OHCAs with evidence of non-prescription drug use, compared to other OHCAs, have not been well described.

METHODS: We included emergency medical service-treated OHCA in the British Columbia Cardiac Arrest Registry (January/2019-June/2023). We classified cases as "non-prescription drug-associated cardiac arrests" (DA-OHCA) if there was evidence of non-prescription drug use preceding the OHCA, including witness accounts of use within 24 h or paraphernalia at the scene. We fit logistic regression models to investigate the association between DA-OHCA (vs. other cases) and favourable neurological outcome (Cerebral Performance Category [CPC] 1-2) and survival at hospital discharge, and return of spontaneous circulation (ROSC).

RESULTS: Of 18,426 OHCA, 2,171 (12%) were classified as DA-OHCA. DA-OHCA tended to be younger, unwitnessed, occur during the evening or night, and present with a non-shockable rhythm, compared to other OHCA. DA-OHCA (221 [10%]) had a greater proportion (difference 1.8%; 95% CI 0.49-3.2) with favourable neurological outcomes compared to other OHCA (1,365 [8.4%]). Adjusted models did not identify an association of DA-OHCA with favourable neurological outcome (OR 1.08, 95% CI 0.87-1.33) or survival to hospital discharge (OR 1.13, 95% CI 0.93-1.38), but did demonstrate an association with ROSC (OR 1.13, 95% CI 1.004-1.27).

CONCLUSION: In unadjusted models, DA-OHCA was associated with an improved odds of survival and favourable neurological outcomes at hospital discharge, compared to other OHCA. However, we did not detect an association in adjusted analyses.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Mok V, Haines M, Nowroozpoor A, et al. The association of non-prescription drug use preceding out-of-hospital cardiac arrest and clinical outcomes. Resuscitation. 2024. PMID: 38996908. doi:10.1016/j.resuscitation.2024.110313

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。